REMSleep Holdings Inc (OTCID: RMSL) is a medical device company that develops and sells CPAP mask products for the treatment of obstructive sleep apnea (OSA). Revenue comes from product sales of its Deltawave CPAP Pillows Mask, sold through durable medical equipment providers, hospitals, sleep labs, and physicians. The company competes directly against ResMed, Philips Respironics, Fisher & Paykel Healthcare, React Health, and Innogen in the CPAP interface market, where more than 8 million masks are sold annually in the U.S. alone (per the FY2025 10-K). REMSleep holds utility patent 10987481, awarded April 27, 2021, and design patent D1,017,025 S, awarded March 5, 2024, both covering the Deltawave mask. As of December 31, 2025, the company carried an accumulated deficit of $18,291,056, reported a net loss of $3,020,300, and used $502,829 in operating cash for FY2025. Its auditors noted substantial doubt about its ability to continue as a going concern. RMSL is a smaller reporting company with no securities registered on a national exchange.

Revenue model

Transactional product sales of CPAP mask devices, primarily the Deltawave CPAP Pillows Mask, sold to durable medical equipment providers, hospitals, sleep labs, and physicians. The company does not directly bill Medicare, Medicaid, or other third-party payers.

Products and services

Deltawave CPAP Pillows Mask, a patented CPAP interface device for delivery of CPAP therapy and treatment of obstructive sleep apnea (OSA). Covered by utility patent 10987481 (awarded April 27, 2021) and design patent D1,017,025 S (awarded March 5, 2024).

Customers and end markets

Durable medical equipment providers, hospitals and acute care facilities, sleep labs, and physicians specializing in sleep and neurology. End market is patients diagnosed with or being treated for obstructive sleep apnea. The filing notes an estimated 80 million people in the U.S. with undiagnosed sleep apnea.

Value-chain role

Medical device manufacturer and IP holder. Sells finished CPAP mask products through healthcare distribution channels including DME providers and clinical facilities. Does not directly submit reimbursement claims to government payers.

Geographic exposure

Primary focus on the U.S. market. The filing notes North America accounts for a majority of the global sleep treatment and equipment market.

Competitors

ResMed, Philips Respironics, Fisher & Paykel Healthcare, React Health, Innogen

Source: SEC 10-K, filed 2026-04-15

Industry: Services-Personal Services Peers: Abbott Laboratories Acutus Medical, Inc. ALR TECHNOLOGIES INC. Delcath Systems Inc Ekso Bionics Holdings Inc Strata Skin Sciences Inc ENDRA Life Sciences Inc Heartbeam Inc MINERVA SURGICAL INC NeuroMetrix, Inc.